Regenicin, Inc.
CIK 0001412659
Revenue (TTM)
—
Q1 Apr 2023
Net Income (TTM)
−$943.69K
−19.8% YoY
Q1 Apr 2023
EPS Diluted (TTM)
$0.00
Q1 Apr 2023
Gross Margin
—
Q1 Apr 2023
Operating Margin
—
Q1 Apr 2023
Net Margin
—
Q1 Apr 2023
Free Cash Flow (TTM)
—
Q1 Apr 2023
Cash
$1.33K
Q1 Apr 2023
Total Debt
—
Q1 Apr 2023
Shares Outstanding
153.48M sh
Q1 Apr 2023
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.